Association of abnormal glucose metabolism and insulin resistance in patients with atypical and typical endometrial cancer

Lai,Yongjing; Sun,Chuanying

doi:10.3892/ol.2017.7590

Association of abnormal glucose metabolism and insulin resistance in patients with atypical and typical endometrial cancer

Authors:
- Yongjing Lai
- Chuanying Sun
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, People's Hospital of Rizhao, Rizhao, Shandong 276800, P.R. China
Published online on: December 12, 2017 https://doi.org/10.3892/ol.2017.7590
Pages: 2173-2178
Copyright: © Lai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study aimed to detect glucose metabolism indicators and insulin resistance index in patients with endometrial cancer, and to explore the clinical significance and correlation between them. A total of 65 patients with endometrial cancer (52 of typical endometrial and 13 cases of atypical endometrial cancer patients, 27 with diabetes mellitus, and 38 cases without diabetes mellitus) were selected at the People's Hospital of Rizhao from June, 2010 to June, 2016 to serve as the observation group. During the same period, 62 patients with endometrial benign lesions (24 with diabetes mellitus and 38 cases without diabetes mellitus) were selected as the control group. General information including height, body weight, body mass index (BMI), abdominal, waist and hip circumference, and waist‑to-hip ratio (WHR) was compared between the two groups. Fasting blood glucose, glycosylated hemoglobin, fasting insulin level (FINS), insulin resistance index (HOMA‑IR), follicle estrogen (FSH), luteinizing hormone and estradiol (estrogen) were detected and compared between the two groups. Multivariate logistic regression was used to analyze the risk factors for endometrial cancer. The results showed that there were no significant differences in the height and hip circumference among the typical, atypical and control groups. By contrast, weight, BMI, waist circumference, abdominal circumference and the WHR of the typical group were significantly higher than those of the atypical and control groups (P<0.05). No significant differences were found between the atypical and control groups (P>0.05). Levels of the FINS and HOMA-IR typical group were significantly higher than those in the atypical and control groups, and the incidence of hyperinsulinemia and insulin resistance was significantly higher in the observation than in the control group (P<0.05). Of the patients with diabetes, the levels of FINS, HOMA-IR and estrogen were significantly higher, but the level of FSH was significantly lower in the observation compared to the control group (P<0.05). For patients without diabetes, significant differences in the levels of FINS and HOMA-IR were found between the observation and control groups (P<0.05). There was no significant difference in the levels of FINS and HOMA-IR among endometrial cancer patients with different pathological features (P>0.05). HOMA-IR (OR=1.240), estrogen (OR=1.192) and FSH (OR=1.002) are risk factors for endometrial cancer. The results suggest that hyperinsulinemia and insulin resistance are risk factors of endometrial cancer. Insulin may therefore be involved in the development of endometrial cancer by affecting the level of sex hormones.

View Figures

View References

1	Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin. 56:106–130. 2006. View Article : Google Scholar : PubMed/NCBI
2	Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
3	Bodner-Adler B, Bodner K, Obermair A, Czerwenka K, Petru E, Leodolter S and Mayerhofer K: Prognostic parameters in carcinosarcomas of the uterus: A clinico-pathologic study. Anticancer Res. 21:3069–3074. 2001.PubMed/NCBI
4	Sanz-Chávez TL, Vilar-Compte D, de Nicola-Delfín L and Meneses-García A: Overweight, obesity, diabetes, and hypertension in endometrial cancer. Rev Med Inst Mex Seguro Soc. 51:326–329. 2013.(In Spanish). PubMed/NCBI
5	Hursting SD and Berger NA: Energy balance, host-related factors, and cancer progression. J Clin Oncol. 28:4058–4065. 2010. View Article : Google Scholar : PubMed/NCBI
6	Liu Y, Tian JW, Xu Y and Cheng W: Role of transvaginal contrast-enhanced ultrasound in the early diagnosis of endometrial carcinoma. Chin Med J. 125:416–421. 2012.PubMed/NCBI
7	Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:412–419. 1985. View Article : Google Scholar : PubMed/NCBI
8	Chen WJ, Liu Y, Sui YB, Zhang B, Zhang XH and Yin XH: Increased circulating levels of musclin in newly diagnosed type 2 diabetic patients. Diab Vasc Dis Res. 14:116–121. 2017. View Article : Google Scholar : PubMed/NCBI
9	Bristow RE: Endometrial cancer. Curr Opin Oncol. 11:388–393. 1999. View Article : Google Scholar : PubMed/NCBI
10	Clement PB and Young RH: Endometrioid carcinoma of the uterine corpus: A review of its pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol. 9:145–184. 2002. View Article : Google Scholar : PubMed/NCBI
11	Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, Krogh V, Lenner P, Shore RE, Biessy C, et al: Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer. 108:425–432. 2004. View Article : Google Scholar : PubMed/NCBI
12	Lax SF, Pizer ES, Ronnett BM and Kurman RJ: Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Hum Pathol. 29:551–558. 1998. View Article : Google Scholar : PubMed/NCBI
13	Singh M, Darcy KM, Brady WE, Clubwala R, Weber Z, Rittenbach JV, Akalin A, Whitney CW, Zaino R, Ramirez NC, et al: Cadherins, catenins and cell cycle regulators: Impact on survival in a gynecologic oncology group phase II endometrial cancer trial. Gynecol Oncol. 123:320–328. 2011. View Article : Google Scholar : PubMed/NCBI
14	Sato E, Nakayama K, Nakamura K, Ishikawa N, Ishikawa M, Minamoto T, Ishibashi T and Kyo S: Efficacy of metformin for advanced-stage endometrial cancer: A case report. Mol Clin Oncol. 6:441–443. 2017. View Article : Google Scholar : PubMed/NCBI
15	Trentham-Dietz A, Nichols HB, Hampton JM and Newcomb PA: Weight change and risk of endometrial cancer. Int J Epidemiol. 35:151–158. 2006. View Article : Google Scholar : PubMed/NCBI
16	Xu WH, Matthews CE, Xiang YB, Zheng W, Ruan ZX, Cheng JR, Gao YT and Shu XO: Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. Am J Epidemiol. 161:939–947. 2005. View Article : Google Scholar : PubMed/NCBI
17	Mu N, Zhu Y, Wang Y, Zhang H and Xue F: Insulin resistance: A significant risk factor of endometrial cancer. Gynecol Oncol. 125:751–757. 2012. View Article : Google Scholar : PubMed/NCBI
18	Kacalska O, Krzyczkowska-Sendrakowska M, Milewicz T, Zabińska-Popiela M, Bereza T, Krzysiek-Maczka G and Krzysiek J: Molecular action of insulin-sensitizing agents). Endokrynol Pol. 56:308–313. 2005.(In Polish). PubMed/NCBI
19	Folsom AR, Anderson KE, Sweeney C and Jacobs DR Jr: Diabetes as a risk factor for death following endometrial cancer. Gynecol Oncol. 94:740–745. 2004. View Article : Google Scholar : PubMed/NCBI
20	Shoff SM and Newcomb PA: Diabetes, body size, and risk of endometrial cancer. Am J Epidemiol. 148:234–240. 1998. View Article : Google Scholar : PubMed/NCBI
21	Salazar-Martínez E, Lazcano-Ponce EC, Lira-Lira GG, Escudero-De los Rios P, Salmerón-Castro J, Larrea F and Hernández-Avila M: Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control. 11:707–711. 2000. View Article : Google Scholar : PubMed/NCBI
22	Qu HQ, Li Q, Rentfro AR, Fisher-Hoch SP and McCormick JB: The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning. PLoS One. 6:e210412011. View Article : Google Scholar : PubMed/NCBI
23	Habib SS, Eshki A, AlTassan B, Fatani D, Helmi H and AlSaif S: Relationship of serum novel adipokine chemerin levels with body composition, insulin resistance, dyslipidemia and diabesity in Saudi women. Eur Rev Med Pharmacol Sci. 21:1296–1302. 2017.PubMed/NCBI
24	Zhang Y, Liu Z, Yu X, Zhang X, Lü S, Chen X and Lü B: The association between metabolic abnormality and endometrial cancer: A large case-control study in China. Gynecol Oncol. 117:41–46. 2010. View Article : Google Scholar : PubMed/NCBI
25	Bray GA: The underlying basis for obesity: Relationship to cancer. J Nutr. 132:3451–3455. 2002.
26	Akhmedkhanov A, Zeleniuch-Jacquotte A and Toniolo P: Role of exogenous and endogenous hormones in endometrial cancer: Review of the evidence and research perspectives. Ann N Y Acad Sci. 943:296–315. 2001. View Article : Google Scholar : PubMed/NCBI
27	Kaaks R, Lukanova A and Kurzer MS: Obesity, endogenous hormones, and endometrial cancer risk: A synthetic review. Cancer Epidemiol Biomarkers Prev. 11:1531–1543. 2002.PubMed/NCBI
28	Osório-Costa F, Rocha GZ, Dias MM and Carvalheira JB: Epidemiological and molecular mechanisms aspects linking obesity and cancer. Arq Bras Endocrinol Metabol. 53:213–226. 2009. View Article : Google Scholar : PubMed/NCBI
29	Takemura Y, Ouchi N, Shibata R, Aprahamian T, Kirber MT, Summer RS, Kihara S and Walsh K: Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest. 117:375–386. 2007. View Article : Google Scholar : PubMed/NCBI
30	Higuchi A, Ohashi K, Shibata R, Sono-Ro manelli S, Walsh K and Ouchi N: Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanism. Arterioscler Thromb Vasc Biol. 30:46–53. 2010. View Article : Google Scholar : PubMed/NCBI